MannKind Corporation (MNKD) financial statements and ratios from SEC XBRL: revenue $0.4B (TTM), net margin 1.7%, revenue growth 22.2% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $348.97M |
| Revenue (TTM) | $0.4B |
| Net Margin | 1.7% |
| Operating Margin (TTM) | -3.6% |
| Net Debt / EBITDA | 43.9 |
| Revenue Growth (YoY) | 22.2% |
| EPS Growth (YoY) | -80.0% |
| FCF Growth (YoY) | -58.3% |
| EV / EBITDA | 50.0 |
| Price / Sales | 3.59 |
| FCF Yield | -1.6% |
| Altman Z-Score | -3.95 (distress) |
| Piotroski F-Score | 3/9 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.7 |
MNKD overview · MNKD earnings · MNKD KPIs · MNKD documents · MNKD ownership · MNKD peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.